Recombinant multi-species SNAI1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SNAI1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The Drosophila embryonic protein snail is a zinc finger transcriptional repressor which downregulates the expression of ectodermal genes within the mesoderm. The nuclear protein encoded by this gene is structurally similar to the Drosophila snail protein, and is also thought to be critical for mesoderm formation in the developing embryo. At least two variants of a similar processed pseudogene have been found on chromosome 2. [provided by RefSeq, Jul 2008]
The Alternative Names of target: Protein snail homolog 1 (Protein sna),SLUGH2,SNA,SNAH,SNAI1,SNAIL,SNAIL1,Sna,Sna1,Snai1,Snail,Snail1,Zinc finger protein SNAI1,dJ710H13.1
Go
to SNAI1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP11499-Ag-1/ GM-Tg-hg-IP11499-Ag-2 | Human SNAI1 protein | Human |
| GM-Tg-rg-IP11499-Ag-1/ GM-Tg-rg-IP11499-Ag-2 | Rat SNAI1 protein | Rat |
| GM-Tg-mg-IP11499-Ag-1/ GM-Tg-mg-IP11499-Ag-2 | Mouse SNAI1 protein | Mouse |
| GM-Tg-cynog-IP11499-Ag-1/ GM-Tg-cynog-IP11499-Ag-2 | Cynomolgus/Rhesus macaque SNAI1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP11499-Ag-1/ GM-Tg-felg-IP11499-Ag-2 | Feline SNAI1 protein | Feline |
| GM-Tg-cang-IP11499-Ag-1/ GM-Tg-cang-IP11499-Ag-2 | Canine SNAI1 protein | Canine |
| GM-Tg-bovg-IP11499-Ag-1/ GM-Tg-bovg-IP11499-Ag-2 | Bovine SNAI1 protein | Bovine |
| GM-Tg-equg-IP11499-Ag-1/ GM-Tg-equg-IP11499-Ag-2 | Equine SNAI1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP11499-Ag-1/ GM-Tg-hg-IP11499-Ag-2;
GM-Tg-rg-IP11499-Ag-1/ GM-Tg-rg-IP11499-Ag-2;
GM-Tg-mg-IP11499-Ag-1/ GM-Tg-mg-IP11499-Ag-2; GM-Tg-cynog-IP11499-Ag-1/ GM-Tg-cynog-IP11499-Ag-2; GM-Tg-felg-IP11499-Ag-1/ GM-Tg-felg-IP11499-Ag-2; GM-Tg-cang-IP11499-Ag-1/ GM-Tg-cang-IP11499-Ag-2; GM-Tg-bovg-IP11499-Ag-1/ GM-Tg-bovg-IP11499-Ag-2; GM-Tg-equg-IP11499-Ag-1/ GM-Tg-equg-IP11499-Ag-2 |
| Products Name | SNAI1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | SNAI1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SNAI1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.